Prot #M14-358: A Phase 1b Study of ABT-199 (GDC-0199) in Combination with Azacitidine or Decitabine in Treatment-Naïve Subjects with Acute Myelogenous Leukemia Who Are ≥ 65 Years of Age and Who Are Not Eligible for Standard Induction Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date4/23/154/23/21

Funding

  • INC Research, LLC (Prot #M14-358)
  • AbbVie Inc. (Prot #M14-358)